{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:51Z","timestamp":1786649751994,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>While anti-tuberculosis drugs (ATDs) are essential for tuberculosis (TB) treatment, they can induce severe hypersensitivity reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Its occurrence presents significant diagnostic and therapeutic challenges, especially in TB patients with type 2 respiratory failure and sepsis. A 23-year-old man with pulmonary TB developed ATD-induced DRESS syndrome complicated by type 2 respiratory failure and sepsis. He developed DRESS syndrome after initiating a standard ATD regimen consisting of rifampicin (R), isoniazid (H), pyrazinamide (Z), and ethambutol (E). He developed progressive dyspnea, fever, nausea, vomiting, and a pruritic, erythematous skin rash. Laboratory findings revealed leukocytosis, eosinophilia, severe transaminitis, hyperbilirubinemia, and elevated interleukin-6 levels. DRESS syndrome was diagnosed based on RegiSCAR scoring system (total score = 6), derived from clinical, physical, and laboratory abnormalities. All ATDs were discontinued, and he received systemic corticosteroids, hepatoprotective agents, topical therapy, and supportive respiratory management. Upon clinical improvement, ATDs desensitization was successfully performed, followed by completion of a modified regimen of rifampicin 450 mg\/isoniazid 200 mg\/ethambutol 750 mg for 9 months, excluding pyrazinamide due to previous hepatic involvement. No recurrence of DRESS manifestations was observed, and sputum acid-fast bacilli examinations at 6 months were negative. Early recognition of ATD-induced DRESS syndrome, prompt withdrawal of the offending drugs, and appropriate treatment are crucial to prevent severe organ involvement. Desensitization protocols provide a safe and effective approach for reintroducing essential ATDs in selected patients, allowing successful completion of TB treatment without DRESS recurrence.<\/jats:p>","DOI":"10.4103\/ijmy.ijmy_76_26","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:00:16Z","timestamp":1774641616000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in Pulmonary Tuberculosis Patient with Type 2 Respiratory Failure and Sepsis"],"prefix":"10.4103","volume":"15","author":[{"given":"Brigita Sanina","family":"Manullang","sequence":"first","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia"},{"name":"Department of Pulmonology and Respiratory Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4627-0511","authenticated-orcid":false,"given":"Isnin Anang","family":"Marhana","sequence":"additional","affiliation":[{"name":"Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia"},{"name":"Department of Pulmonology and Respiratory Medicine, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"R2-20260416","first-page":"519","article-title":"Map of tuberculosis indidence in West Java Province in 2023","volume":"7","author":"Wulandini","year":"2025","journal-title":"Indones J Glob Health Res"},{"key":"R3-20260416","doi-asserted-by":"crossref","first-page":"131","DOI":"10.36347\/sjmcr.2025.v13i01.029","article-title":"Antitubercular therapy-induced DRESS syndrome: A case report","volume":"13","author":"Chaanoun","year":"2025","journal-title":"Sch J Med Case Rep"},{"key":"R4-20260416","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/ijmy.ijmy_78_22","article-title":"Treatment and management of hypersensitivity reactions developed against anti-tuberculosis drug","volume":"11","author":"Katran","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R5-20260416","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"R6-20260416","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: A literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ J"},{"key":"R7-20260416","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/ijmy.ijmy_33_24","article-title":"The unusual adverse effects of antituberculosis therapy in kidney patients","volume":"13","author":"Abdullah","year":"2024","journal-title":"Int J Mycobacteriol"},{"key":"R8-20260416","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1097\/MS9.0000000000000683","article-title":"Drug reaction with eosinophilia and systemic symptoms syndrome secondary to isoniazid and ethambutol: A case report and literature review","volume":"85","author":"Adhikari","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"R9-20260416","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4168\/aair.2019.11.1.90","article-title":"Prevalence and clinical features of drug reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: A retrospective cohort study","volume":"11","author":"Jung","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"R10-20260416","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.4103\/jfmpc.jfmpc_1516_23","article-title":"DRESS syndrome due to anti-TB drugs: A complex case with successful re-desensitization of group A drugs","volume":"13","author":"Mor\u00e1n-Mari\u00f1os","year":"2024","journal-title":"J Family Med Prim Care"},{"key":"R11-20260416","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/ijmy.ijmy_8_23","article-title":"Antitubercular therapy causing drug reaction with eosinophilia and systemic symptoms manifesting multi-organ dysfunction syndrome and death in an elderly patient: A case report with review of literature","volume":"12","author":"Panda","year":"2023","journal-title":"Int J Mycobacteriol"},{"key":"R12-20260416","doi-asserted-by":"crossref","first-page":"130","DOI":"10.18203\/2349-3933.ijam20240365","article-title":"An observed repeat case of drug reaction with eosinophilia and systemic symptoms syndrome with modified anti-tuberculosis therapy: A case report Indu","volume":"11","author":"Priyadarshini","year":"2024","journal-title":"Int J Adv Med"},{"key":"R13-20260416","first-page":"13","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) with anti-tuberculosis drugs, a rare and serious complication","volume":"30","author":"Bouhamdi","year":"2024","journal-title":"Dermatol Online J"},{"key":"R14-20260416","doi-asserted-by":"crossref","first-page":"621","DOI":"10.21474\/IJAR01\/19494","article-title":"Case report on DRESS syndrome induced by antituberculosis drugs","volume":"12","author":"Raghavendra","year":"2024","journal-title":"Int J Adv Res"},{"key":"R15-20260416","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14744\/lhhs.2025.90264","article-title":"An overview of management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"5","author":"Arsoy","year":"2025","journal-title":"Lokman Hekim Health Sci"},{"key":"R16-20260416","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/jpgm.JPGM_746_20","article-title":"DRESS syndrome induced by imatinib","volume":"67","author":"Kaur","year":"2021","journal-title":"J Postgrad Med"},{"key":"R17-20260416","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fmed.2017.00179","article-title":"New insights into drug reaction with eosinophilia and systemic symptoms pathophysiology","volume":"4","author":"Musette","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"R18-20260416","first-page":"104512","article-title":"Management of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a female Indonesian with pulmonary tuberculosis: A rare case report","volume":"81","author":"Permatasari","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"R19-20260416","doi-asserted-by":"crossref","first-page":"333","DOI":"10.21911\/aai.2024.636","article-title":"Drug reaction syndrome with eosinophilia and systemic symptoms (DRESS) syndrome associated with anti-tuberculosis therapy: A case report","volume":"22","author":"Atika","year":"2024","journal-title":"Asthma Allergy Immunol"},{"key":"R20-20260416","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.3390\/jcm12144576","article-title":"Renal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A systematic review of 71 cases","volume":"12","author":"Dagnon da Silva","year":"2023","journal-title":"J Clin Med"},{"key":"R21-20260416","doi-asserted-by":"crossref","first-page":"100935","DOI":"10.1016\/j.waojou.2024.100935","article-title":"The systemic treatments for drug reaction with eosinophilia and systemic symptoms (DRESS) beyond corticosteroids","volume":"17","author":"Wang","year":"2024","journal-title":"World Allergy Organ J"},{"key":"R22-20260416","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"R23-20260416","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome","volume":"30","author":"Caba\u00f1as","year":"2020","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_76_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:00Z","timestamp":1786647480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_76_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_76_26","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-01-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}